June, 2020 - SAVIMS

COVID-19, Ethics, Other repurposed substances, Peer-reviewed evidence, Reference Library, Resource Type, Treatment, Viral illnesses

The Retraction of a Controversial Study on COVID-19 Treatments

SAVIMS | 04/06/2020 | COVID-19, Ethics, Other repurposed substances, Peer-reviewed evidence, Reference Library, Resource Type, Treatment, Viral illnesses

Reference: Mehra, M. R., Desai, S. S., Ruschitzka, F., & Patel, A. N. (2020). Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: A multinational registry analysis. The Lancet, published online May 22, https://doi.org/10.1016/S0140-6736(20)31180-6 Summary: In June 2020, The Lancet announced the retraction of a significant study assessing the effectiveness of hydroxychloroquine […]

COVID-19, Covid-19 vaccines, Ethics, Reference Library, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Guidance on COVID-19 Vaccine Development

SAVIMS | 01/06/2020 | COVID-19, Covid-19 vaccines, Ethics, Reference Library, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: U.S. Department of Health and Human Services. (2020). Contains nonbinding recommendations: Development and licensure of vaccines to prevent COVID-19 guidance for industry. Food and Drug Administration. Summary: In June 2020, the U.S. Food and Drug Administration (FDA) issued guidance to assist the development and licensure of COVID-19 vaccines amidst the public health emergency. This